MAPT and Alzheimer disease: Alzheimer's disease (AD) is a progressive neurodegenerative disorder, neuropathologically characterised by fibrillar aggregates of the microtubule-associated protein tau and the amyloid β-peptide (Aβ), giving rise to the characteristic hallmarks of the disease in the form of neurofibrillary tangles and neuritic plaques, respectively.